Dr. Jan Groen is the Chairman and Chief Executive Officer of Intravacc. He was previously the CEO of Novigenix (CH), a privately-owned immunotranscriptomic diagnostic company, and MDxHealth, a Public-listed genomic diagnostics company in the USA. His career spans many years in the global life science sector. He was the President and COO of Agendia (USA), co-founder of ViroClinics and DxOrange, and has held management and scientific positions at Focus Diagnostics (USA), the Erasmus Medical Center, the National Institute of Public Health, and Akzo-Nobel. Currently he is investment advisor at Oncode Institute, Chairman of the Board of Angle Plc. (UK), Board member of SPL Medical and Novigenix (CH). He has published over 125 papers in international scientific journals and holds a PhD in Medical Microbiology from Erasmus University Rotterdam.